A protocol for genetic evaluation of patients with multiple colorectal adenomas and without evidence of APC gene mutation

Keyphrases

• Patient Assessment 100%
• Exon 100%
• Genetic Evaluation 100%
• APC mutation 100%
• Multiple Colorectal Adenomas 100%
• APC Gene 100%
• Lynch Syndrome 75%
• Bethesda 50%
• North African 50%
• Mutation-negative 50%
• African Ancestry 50%
• Jewish 25%
• Israel 25%
• Jews 25%
• Counseling 25%
• Polymorphism 25%
• National Health Insurance 25%
• Duplication 25%
• Sequence Analysis 25%
• Gene Sequencing 25%
• Treatment Burden 25%
• Clinical Criteria 25%
• Evaluation Protocol 25%
• Colorectal Cancer 25%
• Economic Burden 25%
• Genetic Analysis 25%
• Amsterdam 25%
• Copy number Analysis 25%
• Colonic Adenoma 25%
• Multiplex Ligation-dependent Probe Amplification 25%
• Laboratory Investigation 25%
• Variants of Uncertain Significance 25%
• Colorectal Adenomatous Polyps 25%
• Gene Copy number Variation 25%
• Immunohistology 25%
• MUTYH Gene 25%
• MUTYH 25%
• Positive Criteria 25%
• MLH1 Gene 25%
• Polyposis 25%
• Microsatellite Instability-high (MSI-H) 25%
• MUTYH mutations 25%

Biochemistry, Genetics and Molecular Biology

• Exon 100%
• Genetic Evaluation 100%
• Gene Mutation 100%
• MUTYH 75%
• Copy-Number Variation 50%
• Genetics 25%
• Gene Dosage 25%
• MLH1 25%
• Gene Sequence 25%
• Multiplex Ligation-Dependent Probe Amplification 25%
• Microsatellite Instability 25%

Neuroscience

• Gene Mutation 100%
• Exon 100%
• Copy Number Variation 50%
• Gene Sequence 25%
• Multiplex Ligation-Dependent Probe Amplification 25%
• Gene Dosage 25%
• Microsatellite Instability 25%